HOT TOPICS Drug/Device Combination Products - Considerations for product development and lifecycle management
Kurs
In Amsterdam ((Wählen))
Beschreibung
-
Kursart
Kurs
-
Ort
Amsterdam ((Wählen))
-
Dauer
2 Tage
-
Beginn
nach Wahl
- Current and future regulatory framework
- Submission and quality requirements
- Article 117 MDR and its impact on drug-device combination (DDCs) products
- Clinical considerations and vigilance obligations
- Drugs combined with medical apps
Standorte und Zeitplan
Lage
Beginn
Beginn
Hinweise zu diesem Kurs
This seminar is aimed at specialists and managers in the pharmaceutical and medical-device industries. Employees dealing with borderline issues in the areas of approval, certification, clinical/medical affairs, quality assurance and vigilance, can benefit greatly from this seminar.
Meinungen
Erfolge dieses Bildungszentrums
Sämtlich Kurse sind auf dem neuesten Stand
Die Durchschnittsbewertung liegt über 3,7
Mehr als 50 Meinungen in den letzten 12 Monaten
Dieses Bildungszentrum ist seit 16 Mitglied auf Emagister
Themen
- Management
- DDC
- MDR
- Product
- Quality
- Quality Risk Management
- Pharma
- Pharmazie
- Pharma-Marketing
- Pharmatechnik
Inhalte
- be able to classify your product in the correct product group,
- know the consequences of current case law for the development, approval and post-marketing surveillance of your product,
- know the impact of Article 117 MDR and
- discuss the new quality requirement for DDCs.
HOT TOPICS Drug/Device Combination Products - Considerations for product development and lifecycle management